Mo Yi

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• German Center for Neurodegenerative Diseases11.2%
• Novartis (Switzerland)8.4%
• Shionogi (Japan)8.4%
• Futaba (Japan)8.3%
• Eli Lilly (United States)8.1%
• Inserm7.7%
• Other47.8%

Fields

• Medicine69.1%
• Biochemistry, Genetics and Molecular Biology10%
• Neuroscience7%
• Computer Science6.3%
• Health Professions1.9%
• Economics, Econometrics and Finance1%
• Other4.5%

Topics

• Alzheimer's disease research and treatments36.4%
• Cholinesterase and Neurodegenerative Diseases15.5%
• Dementia and Cognitive Impairment Research13.3%
• Computational Drug Discovery Methods9.9%
• Neuroinflammation and Neurodegeneration Mechanisms5.5%
• Tryptophan and brain disorders3.7%
• Other15.7%